This study aims to evaluate the effectiveness and tolerability of once-weekly glucagon-like peptide receptor agonists (OW GLP-1RAs) and to assess the clinical benefits of switching from one GLP-1RA to another (switchers) in a routine clinical setting.
Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 Diabetes
Di Dalmazi, GiuliaPrimo
;Baldassarre, Maria Pompea Antonia;Ghit, Amr;Ciappini, Beatrice;Milo, Marica;Carrieri, Federica;Consoli, AgostinoPenultimo
;Formoso, Gloria
Ultimo
2022-01-01
Abstract
This study aims to evaluate the effectiveness and tolerability of once-weekly glucagon-like peptide receptor agonists (OW GLP-1RAs) and to assess the clinical benefits of switching from one GLP-1RA to another (switchers) in a routine clinical setting.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Di Dalmazi-Coluzzi 2022.pdf
accesso aperto
Descrizione: pdf editoriale
Tipologia:
PDF editoriale
Dimensione
616.1 kB
Formato
Adobe PDF
|
616.1 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
